Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)

被引：0

作者：

Zambrano, M. D. C. Beato ^{[1
]}

Lemaire, A. ^{[2
]}

Montesarchio, V. ^{[3
]}

Sabate, J-M. ^{[4
]}

Serna i Mont-Ros, J. ^{[5
]}

Namane, R. ^{[6
]}

Baccarelli, S. Martin ^{[7
]}

Rico-Villademoros, F. ^{[8
]}

Cobo, M. ^{[9
]}

机构：

[1] Hosp Univ Jerez, Oncol Med, Jerez de la Frontera, Spain

[2] Valenciennes Gen Hosp, Oncol & Med Specialties Dept, Valenciennes, France

[3] Monaldi Hosp, Pneumol & Oncol, Naples, Italy

[4] Hop Avicenne, AP HP, Gastroenterol & Digest Oncol, Bobigny, France

[5] Hosp Univ Barcelona, Oncol, Campus Vall Hebron, Barcelona, Spain

[6] Kyowa Kirin Pharma SAS, Med Affairs, Neuilly Sur Seine, France

[7] Apices Soluc SL, Stat, Pinto, Spain

[8] Apices Soluc SL, Med, Pinto, Spain

[9] Hospit Univ Reg & Virgen Victoria Malaga, Med Oncol, IBIMA Inst Invest Biomed Malaga, Malaga, Spain

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.861

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2079P

引用

页码：S1094 / S1094

页数：1

共 50 条

[41] Pharmacologic Profile of Naloxegol, a Peripherally Acting μ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
Floettmann, Eike
Bui, Khanh
Sostek, Mark
Payza, Kemal
Eldon, Michael
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 361 (02): : 280 - 291
[42] Inadequate management of opioid-induced constipation in European cancer pain patients: results of a real-world, multicentre, observational study ("E-StOIC")
Davies, Andrew
Fagan, Norah
Gonzalez-Barboteo, Jesus
Chelazzi, Cosimo
Economos, Guillaume
Elsner, Frank
Leach, Charlotte
Monsen, Ragnhild E.
Oldenmenger, Wendy H.
Remi, Constanze
van den Beuken-van Everdingen, Marieke
Wuestefeld, Marion
SUPPORTIVE CARE IN CANCER, 2024, 32 (10)
[43] Correction to: Effectiveness of naloxegol in patients with cancer pain suffering from opioid‑induced constipation
Antoine Lemaire
Yoann Pointreau
Bérengère Narciso
François‑Xavier Piloquet
Viorica Braniste
Jean‑Marc Sabaté
Supportive Care in Cancer, 2021, 29 : 7587 - 7589
[44] Safety and efficacy of naldemedine in cancer patients with opioid-induced constipation: a pooled, subgroup analysis of two randomised controlled studies
Osaka, Iwao
Ishiki, Niroto
Yokota, Takaaki
Tada, Yukio
Sato, Hiroki
Okamoto, Masaharu
Satomi, Eriko
ESMO OPEN, 2019, 4 (04)
[45] Population Exposure-Response Modeling of Naloxegol in Patients With Noncancer-Related Pain and Opioid-Induced Constipation
Al-Huniti, N.
Nielsen, J. C.
Hutmacher, M. M.
Lappalainen, J.
Cantagallo, K.
Sostek, M.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (07): : 359 - 366
[46] Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation
Webster, L.
Chey, W. D.
Tack, J.
Lappalainen, J.
Diva, U.
Sostek, M.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (07) : 771 - 779
[47] Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Noncancer Pain
Rauck, R. L.
Peppin, J. F.
Israel, R. J.
Carpenito, J.
Cohn, J.
Huang, S.
Bortey, E.
Paterson, C.
Forbes, W. P.
GASTROENTEROLOGY, 2012, 142 (05) : S160 - S160
[48] Opioid-induced constipation among a convenience sample of Patients with cancer Pain
Coyne, Karin S.
Sexton, Chris
LoCasale, Robert J.
King, Frederic R.
Margolis, Mary Kay
Ahmedzai, Sam H.
FRONTIERS IN ONCOLOGY, 2016, 6
[49] Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later
Alvaro, Domenico
Coluzzi, Flaminia
Gianni, Walter
Lugoboni, Fabio
Marinangeli, Franco
Massazza, Giuseppe
Pinto, Carmine
Varrassi, Giustino
PAIN AND THERAPY, 2022, 11 (02) : 477 - 491
[50] Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later
Domenico Alvaro
Flaminia Coluzzi
Walter Gianni
Fabio Lugoboni
Franco Marinangeli
Giuseppe Massazza
Carmine Pinto
Giustino Varrassi
Pain and Therapy, 2022, 11 : 477 - 491

← 1 2 3 4 5 →